Day: September 18, 2020

SAN DIEGO, Sept. 18, 2020 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT” or the “Company”), announced that together with its Joint Venture partner, Alpha EDA, LLC (“Alpha”), that it is now in the process of updating its Epsilon, IC (integrated circuit) reliability clean-by-construction program, preparing for advanced manufacturing nodes.As foundries are now offering advanced IC manufacturing processes, fabless customers will have to decide whether to design and manufacture their next microchips around the current stable process or to move to a different one at 5nm and the upcoming 3nm. As 7nm is stable and already in successful use by semiconductor companies, the path to further advanced nodes, like 3nm is still convoluted due to the fact that foundries are still working on its breakthroughs. In general,...

STAMFORD, Conn., Sept. 18, 2020 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that it has entered into a sponsored research agreement with Fred Hutchinson Cancer Research Center (Fred Hutch) to further explore the ability of SpringWorks’ investigational gamma secretase inhibitor (GSI), nirogacestat, to modulate B-cell maturation antigen (BCMA) and potentiate BCMA-targeting therapies, including radioimmunotherapies, in a variety of preclinical and patient-derived multiple myeloma models developed by researchers at Fred Hutch. Damian Green, M.D., Associate Member of the Clinical Research Division at Fred Hutch and Associate Professor at the University of Washington...

Singapore, Sept. 18, 2020 (GLOBE NEWSWIRE) — Moxian, Inc. (“Moxian” or the “Company”) (MOXC), an offline-to-online (O2O) social media services and Internet media marketing services provider, today announces it has received a letter from Nasdaq, stating that the Company has regained compliance on a listing rule regarding the market value of the Company’s listed securities.As previously disclosed, the Company has been notified that by Nasdaq that for the last 30 consecutive business days prior to March 20, 2020, the market value of the Company’s listed securities was less than $35 million, which did not meet the requirement for continued listing on The Nasdaq Capital Market (the “Market Value Rule”). In accordance with Nasdaq Listing Rules, Nasdaq provided the Company until September 16, 2020, to regain compliance with the Market Value...

Savosolar PlcCompany Announcement, Insider information    18 September 2020 at 12.15 p.m. (CEST)Savosolar resolved on a directed share issue without consideration to the Board membersThe Board of Directors of Savosolar Plc (”Savosolar”) has resolved on a directed share issue to be used as a part of the Board members’ remuneration in accordance with the resolution by the Annual General Meeting on 27 April 2020.The Annual General Meeting of the company held on 27 April 2020 resolved that the members of the Board of Directors be paid the following remuneration for the term that begins at the end of the Annual General Meeting and ends at the end of the next Annual General Meeting: EUR 21,600 for the Chairman of the Board and EUR 10,800 for each of the other members of the Board. Approximately 40 per cent of the remuneration to be paid to...

Savosolar OyjYhtiötiedote, Sisäpiiritieto            18.9.2020 klo 12.15 (CEST)Savosolar päätti suunnatusta maksuttomasta osakeannista hallituksen jäsenilleSavosolar Oyj:n (”Savosolar”) hallitus on osana hallituksen jäsenten palkkiojärjestelyjä päättänyt suunnatun osakeannin järjestämisestä 27.4.2020 pidetyn varsinaisen yhtiökokouksen tekemän päätöksen mukaisesti.Yhtiön 27.4.2020 pidetty varsinainen yhtiökokous päätti, että hallituksen jäsenille maksetaan yhtiökokouksen päättyessä alkavalta ja valintaa seuraavan varsinaisen yhtiökokouksen päättyessä päättyvältä toimikaudelta seuraavat palkkiot: hallituksen puheenjohtajalle 21.600 euroa ja muille hallituksen jäsenille kullekin 10.800 euroa. Noin 40 % hallituksen jäsenille maksettavista palkkioista maksetaan hallituksen osakeantivaltuutuksen perusteella antamalla hallituksen jäsenille yhtiön...

Genetron Health to present data at ESMO 2020 relating to precision oncology diagnostic development initiatives across lung, gastrointestinal and other cancer types, and to bioinformatics developmentBEIJING, Sept. 18, 2020 (GLOBE NEWSWIRE) — Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening and companion diagnostics development, and its collaborators will present data from 18 studies at the upcoming European Society for Medical Oncology (ESMO) Virtual Congress 2020 taking place on September 19-21.The abstracts include 15 studies on translational medicine covering various cancer types and three studies on bioinformatics development. Data that will be highlighted at the ESMO...

See attachedAttachmentEsoft_First-North_Nr151 _- UK

Se vedhæftedeVedhæftet filEsoft_First-North_Nr 151_Ledende medarb_DK